Earnings Call · Q1 FY2022·2021-08-24

Q1 22EPS +6.82%·Rev n/aQ4 21EPS +5.63%·Rev n/aQ3 21EPS +12.17%·Rev n/aQ2 21EPS +27.50%·Rev n/a⚠ consensus missing

Medtronic plc MDT

Ryan Weispfenning — Vice President and Head of Investor Relations

Geoffrey Martha — Chairman and Chief Executive Officer

Karen Parkhill — Chief Financial Officer

Francesca DeMartino — Operator / IR or Moderator

−1.0%1d on move date−1.2% vs SPY3d−0.6%5d+1.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MDT calls or request research access.

More MDT calls Browse calls Request research access